SBFM · Sunshine Biopharma Inc
United States · RS rating 2 · As of 2026-11-03
| Price | 2.74 USD |
|---|---|
| 1-day change | -0.4% |
| RS rating (overall / 1M / 3M / 12M) | 2 / 2 / 2 / 2 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 25 / 2 / 50 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +54.0% |
| Sales growth Q/Q | -8.9% |
| Distance from 52-week high | +99.2% |
| Market cap (USD) | $4.9M |